ProQR Therapeutics N.V. - PRQR

About Gravity Analytica
Recent News
- 02.09.2026 - ProQR Announces Planned Changes to Board Composition
- 02.09.2026 - ProQR Announces Planned Changes to Board Composition
- 10.20.2025 - ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025
- 10.20.2025 - ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025
- 10.13.2025 - ProQR to Participate in Upcoming Investor Conferences in October 2025
- 10.13.2025 - ProQR to Participate in Upcoming Investor Conferences in October 2025
Recent Filings
- 02.09.2026 - EX-99.1 EX-99.1
- 02.09.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 02.06.2026 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
- 01.20.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
- 01.08.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 01.08.2026 - EX-99.1 EX-99.1
- 11.06.2025 - EX-99.1 EX-99.1
- 11.06.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 11.03.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 11.03.2025 - EX-99.1 EX-99.1